seed
Stage
About
Antigenix Therapeutics develops antibody-based therapies utilizing a patented platform targeting cancer-specific markers to create precise antibody-drug conjugate treatments for aggressive and treatment-resistant cancers.
Explore Antigenix Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.